134 related articles for article (PubMed ID: 10037445)
21. Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.
Masuyer G; Douglas RG; Sturrock ED; Acharya KR
Sci Rep; 2015 Sep; 5():13742. PubMed ID: 26403559
[TBL] [Abstract][Full Text] [Related]
22. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
Azizi M; Junot C; Ezan E; Hallouin MC; Guyene T; Ménard J
J Mol Med (Berl); 2002 Aug; 80(8):492-8. PubMed ID: 12185449
[TBL] [Abstract][Full Text] [Related]
23. Exclusion of angiotensin I-converting enzyme as a candidate gene involved in exudative inflammatory resistance in F344/N rats.
Jafarian-Tehrani M; Listwak S; Barrientos RM; Michaud A; Corvol P; Sternberg EM
Mol Med; 2000 Apr; 6(4):319-31. PubMed ID: 10949912
[TBL] [Abstract][Full Text] [Related]
24. In vitro effect of acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) analogs resistant to angiotensin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation.
Gaudron S; Grillon C; Thierry J; Riches A; Wierenga PK; Wdzieczak-Bakala J
Stem Cells; 1999; 17(2):100-6. PubMed ID: 10195570
[TBL] [Abstract][Full Text] [Related]
25. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
[TBL] [Abstract][Full Text] [Related]
26. Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography.
Cheviron N; Rousseau-Plasse A; Lenfant M; Adeline MT; Potier P; Thierry J
Anal Biochem; 2000 Apr; 280(1):58-64. PubMed ID: 10805521
[TBL] [Abstract][Full Text] [Related]
27. Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.
Deddish PA; Wang LX; Jackman HL; Michel B; Wang J; Skidgel RA; Erdös EG
J Pharmacol Exp Ther; 1996 Dec; 279(3):1582-9. PubMed ID: 8968386
[TBL] [Abstract][Full Text] [Related]
28. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.
Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED
FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546
[TBL] [Abstract][Full Text] [Related]
29. Characterization of angiotensin I-converting enzyme N-domain selectivity using positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides.
Bersanetti PA; Sabatini RA; Matos BS; Douglas RG; Nchinda A; Juliano MA; Pesquero JB; Sturrock ED; Carmona AK
Biol Chem; 2012 Dec; 393(12):1547-54. PubMed ID: 23667908
[TBL] [Abstract][Full Text] [Related]
30. Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.
Oliveira CR; Paredes-Gamero EJ; Barbosa CM; Nascimento FD; Batista EC; Reis FC; Martins AH; Ferreira AT; Carmona AK; Pesquero JB; Tersariol IL; Araújo RC; Bincoletto C
Chem Biol Interact; 2010 Mar; 184(3):388-95. PubMed ID: 20096676
[TBL] [Abstract][Full Text] [Related]
31. Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides.
Masuyer G; Schwager SL; Sturrock ED; Isaac RE; Acharya KR
Sci Rep; 2012; 2():717. PubMed ID: 23056909
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury.
Li P; Xiao HD; Xu J; Ong FS; Kwon M; Roman J; Gal A; Bernstein KE; Fuchs S
Am J Pathol; 2010 Sep; 177(3):1113-21. PubMed ID: 20651228
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for the C-domain-selective angiotensin-converting enzyme inhibition by bradykinin-potentiating peptide b (BPPb).
Sturrock ED; Lubbe L; Cozier GE; Schwager SLU; Arowolo AT; Arendse LB; Belcher E; Acharya KR
Biochem J; 2019 May; 476(10):1553-1570. PubMed ID: 31072910
[TBL] [Abstract][Full Text] [Related]
34. Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.
Fuchs S; Xiao HD; Cole JM; Adams JW; Frenzel K; Michaud A; Zhao H; Keshelava G; Capecchi MR; Corvol P; Bernstein KE
J Biol Chem; 2004 Apr; 279(16):15946-53. PubMed ID: 14757757
[TBL] [Abstract][Full Text] [Related]
35. A novel angiotensin I-converting enzyme mutation (S333W) impairs N-domain enzymatic cleavage of the anti-fibrotic peptide, AcSDKP.
Danilov SM; Wade MS; Schwager SL; Douglas RG; Nesterovitch AB; Popova IA; Hogarth KD; Bhardwaj N; Schwartz DE; Sturrock ED; Garcia JG
PLoS One; 2014; 9(2):e88001. PubMed ID: 24505347
[TBL] [Abstract][Full Text] [Related]
36. N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.
Kanasaki K
J Diabetes Investig; 2020 May; 11(3):516-526. PubMed ID: 31997585
[TBL] [Abstract][Full Text] [Related]
37. Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme.
Kröger WL; Douglas RG; O'Neill HG; Dive V; Sturrock ED
Biochemistry; 2009 Sep; 48(35):8405-12. PubMed ID: 19658433
[TBL] [Abstract][Full Text] [Related]
38. Naturally occurring active N-domain of human angiotensin I-converting enzyme.
Deddish PA; Wang J; Michel B; Morris PW; Davidson NO; Skidgel RA; Erdös EG
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7807-11. PubMed ID: 8052664
[TBL] [Abstract][Full Text] [Related]
39. Establishment and clinical application of a highly sensitive enzyme immunoassay for determination of N-acetyl-seryl-aspartyl-lysyl-proline.
Suzuki Y; Itoh H; Katagiri F; Sato F; Kawasaki K; Sato Y; Mimata H; Takeyama M
J Pept Sci; 2012 Apr; 18(4):276-81. PubMed ID: 22396066
[TBL] [Abstract][Full Text] [Related]
40. Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.
Nitta K; Shi S; Nagai T; Kanasaki M; Kitada M; Srivastava SP; Haneda M; Kanasaki K; Koya D
Biomed Res Int; 2016; 2016():9172157. PubMed ID: 27088094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
